Name

Jointown Pharmaceutical Group

Legal name

九州通医药集团股份有限公司

Website

https://jztey.com

Company type

Public

Founded year

1999

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Jointown Pharmaceutical Group is a publicly listed Chinese pharmaceutical distributor and supply chain platform that integrates upstream drug and device manufacturers with downstream hospitals, pharmacies, e-commerce, and healthcare platforms through GSP-certified nationwide logistics infrastructure and proprietary B2B digital platforms including 药九九 and the 好药师 retail pharmacy brand.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution and Supply Chain Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmaceutical Preparation Manufacturing (325412)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Full-Line Pharmaceutical Wholesalers (HLAIAJAA)

akta.pro secondary industries

Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops) (CRAOAHAK), Pharmaceutical & Life Sciences Warehousing (GDP-Compliant) (TLAIACAD), Pharmacy Logistics, Returns, Reverse Distribution & Compliance Services (CRAOAHAJ)

Keywords

• Pharmaceutical distribution
• Pharmaceutical supply chain
• Medical device distribution
• Pharmaceutical logistics
• Drug retail pharmacy

Headquarters

HQ city

Wuhan

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Digital Pharmaceutical Distribution and Supply Chain: Core revenue stream. Company operates at the mid-stream of the pharmaceutical industry chain, integrating upstream pharmaceutical and medical device manufacturers and agents with downstream hospitals, pharmacies, e-commerce platforms, and distributors. Generates hundreds of billions in annual sales through transaction fees and logistics service fees.
2. Total Brand Promotion (总代品牌推广): CSO-style brand promotion service based on new product strategy and full-category, full-channel resource advantages. Focuses on retail channels, product value identification and introduction, brand planning and operations, and full-lifecycle brand management. Generates billions in revenue from tens of thousands of pharmaceutical and device SKUs.
3. Pharmaceutical Manufacturing and OEM: Self-operated industrial products and OEM products developed using big data from the trillion-yuan supply chain platform. Covers Western medicine, traditional Chinese medicine, and medical devices, distributed through the full-channel sales network to terminal channels and C-end consumers.
4. New Retail (医药新零售): Retail business under the 好药师 brand covering direct-run chain stores, franchise expansion, specialty pharmacies, B2C online pharmacy, O2O instant retail, and health insurance. Generates billions from franchisee sales and hundreds of millions from B2C e-commerce total agency services.
5. Healthcare and Technology Value-Added Services: Medical diagnosis and health eldercare services, plus proprietary IT development providing technology empowerment and value-added services to customers. Generates hundreds of millions in sales from healthcare and technology services.
6. Digital Logistics Technology and Supply Chain Solutions: Three-party logistics, pharmaceutical cold chain logistics, digital logistics and supply chain services, and intelligent logistics equipment support provided to industry and external customers. Generates hundreds of millions in sales from logistics and supply chain solutions.

Go-to-market motion2 records

Distribution channels6 records

Marketing channels4 records

Core offering

Jointown Pharmaceutical Group operates as a mid-stream pharmaceutical distribution and supply chain integrator in China, connecting upstream drug and medical device manufacturers and agents with downstream hospitals, pharmacies, e-commerce platforms, and distributors. The company runs six business segments: digital pharmaceutical distribution, total brand promotion (CSO), pharmaceutical manufacturing and OEM, new retail pharmacy under the 好药师 brand, healthcare and technology value-added services, and digital logistics and supply chain solutions, all supported by a nationwide GSP-certified warehouse, transportation, and digital intelligence network.

Differentiator

Problem solved

Functional benefit

Brands

• 好药师 (Hao Yao Shi): Retail pharmacy brand for new retail business
• 药九九
• 全擎健康

Products and services

• Digital Pharmaceutical Distribution and Supply Chain
• Total Brand Promotion (CSO) Brand promotion and CSO services based on a new product strategy and full-category, full-channel resource advantages, focused on retail channels, product value identification, brand planning and operations, and full-lifecycle brand management for pharmaceutical brands.
• Pharmaceutical Manufacturing and OEM Self-operated pharmaceutical manufacturing and OEM business covering Western medicine, traditional Chinese medicine, and medical devices, developed using big data from the company's distribution platform and distributed through the full-channel sales network.
• New Retail Pharmacy (好药师) Retail business under the 好药师 (Hao Yao Shi) brand covering direct-run chain stores, franchise expansion (万店加盟), specialty pharmacies, B2C online pharmacy, O2O instant retail, and health insurance.
• Healthcare and Technology Value-Added Services Medical diagnosis, health management, and self-developed IT-enabled value-added services provided to customers as part of the supply chain platform.
• Digital Logistics and Supply Chain Solutions (九州通物流) Nationwide three-network integration logistics supply chain system combining GSP-compliant storage networks, efficient transport networks, and digital intelligence information networks. Provides third-party logistics, pharmaceutical cold chain logistics, digital logistics services, and intelligent logistics equipment to industry and external customers.
• 药九九 (Yao Jiu Jiu) B2B Platform B2B digital pharmaceutical trading platform enabling registered users to conduct pharmaceutical procurement, supply chain management, and digital sales. Reported over 40,000 registered users.
• 好药师 (Hao Yao Shi) Retail Brand Flagship retail pharmacy brand operating direct-run chain stores, franchise stores, specialty pharmacies, B2C online pharmacy, and O2O instant retail.
• 珍药材 (Zhen Yao Cai) TCM Materials Platform Medicinal materials sourcing and trading platform enabling procurement and trade of traditional Chinese medicine materials.

Quantifiable outcome

• Revenue 1,193.27 billion yuan in Q1–Q3 2025, up 5.20% YoY
• +3 more outcomes

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators6 records

Others

• Cardinal Health: Major U.S. pharmaceutical distributor with global medical product distribution. Comparable to Jointown as a benchmark for full-line pharma distribution, healthcare supply chain services, and the strategic role of CSO and value-added services in offsetting low-margin wholesale economics.
• McKesson Corporation: North America's largest pharmaceutical distributor and healthcare services company. Comparable to Jointown as a global reference point for full-line pharmaceutical wholesaling, GSP-equivalent logistics, and CSO-style manufacturer services — though operating in a fundamentally different regulatory and reimbursement environment.

Emerging players

• JD Health International: Online healthcare and pharmaceutical retail platform built on JD.com's logistics infrastructure. Comparable to Jointown's digital pharmacy, B2C, and O2O new retail initiatives, and similarly leverages proprietary logistics — but lacks Jointown's broad-line traditional wholesale franchise.
• Alibaba Health Information Technology: Digital healthcare platform operating B2B pharmaceutical distribution, B2C pharmacy, and healthcare services. Comparable to Jointown's 药九九 B2B platform and 好药师 B2C pharmacy as a digital-native distribution disruptor, though with less traditional wholesale infrastructure.
• Ping An Healthcare and Technology (Good Doctor): Digital healthcare platform offering online consultations, B2C pharmacy, and healthcare value-added services. Comparable to Jointown's healthcare technology value-added services and online pharmacy segments, but focused on consumer-facing health services rather than wholesale distribution.

Broad incumbents

• Shanghai Pharmaceuticals Holding: Major state-controlled pharmaceutical distributor and manufacturer in China. Comparable to Jointown across both pharmaceutical distribution and manufacturing/OEM, with a broader product portfolio and stronger manufacturing vertical integration but similar exposure to VBP-driven margin pressure.
• Sinopharm Group: China's largest state-owned pharmaceutical distributor and one of the world's biggest. Directly comparable to Jointown as a full-line pharmaceutical wholesaler serving hospitals, pharmacies, and manufacturers across China, but with materially larger scale, deeper tier-1 hospital penetration, and government procurement advantages.
• China Resources Pharmaceutical Group: State-owned pharmaceutical and healthcare distribution platform under China Resources. Competes with Jointown in hospital supply, retail pharmacy distribution, and pharmaceutical wholesale, with strong central-government backing and vertically integrated drug manufacturing.

Regional players

• Yunnan Baiyao Group: Leading Chinese TCM and healthcare products manufacturer with integrated distribution. Comparable to Jointown's TCM and healthcare product distribution, with strong consumer brand equity but a more upstream-focused business model.
• Yiling Pharmaceutical: Major Chinese TCM manufacturer and distributor with growing pharmacy and distribution capabilities. Comparable to Jointown's TCM manufacturing (Jiuxin Chinese Medicine) and 珍药材 TCM trading platform as a TCM-focused participant in the same ecosystem.

Market position

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries9 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments11 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Jointown Pharmaceutical Group